Iodine Deficiency Disorder (IDD) is one of the major worldwide public health issues. An insufficient dietary intake of iodine results in insufficient production of thyroid hormones. Tissues are negatively affected due to insufficient hormone production, which leads to the disease states referred collectively as iodine deficiency disorders, or IDD. Extreme and prolonged iodine deficiency may result in a deficient supply of thyroid hormones. This condition is known as hypothyroidism. IDD is a rare endocrinology illness in which the thyroid gland in the neck produces insufficient amounts or is incapable of creating thyroid hormone owing to a lack of iodine, which is a vital nutrient for the growth and function of the thyroid gland. The body's metabolism, temperature, and heart rate regulation is the responsible of the thyroid hormone. As per the World Health Organization (WHO), approximately 2 billion people around the world are at risk of iodine deficiency, and it is projected that iodine deficiency impacts around 30% of the world population. This rising prevalence is augmenting the demand for iodine deficiency drugs eventually, market growth. Moreover, iodine deficiency causes several issues, ranging from miscarriage and stillbirth to physical and mental retardation and hearing. On the other hand, the adverse impacts associated with levothyroxine drug used for hypothyroidism may limit the market growth. The Iodine Deficiency Drug Market is estimated to grow at a rate of 5.6% CAGR by 2027.

Iodine Deficiency Drug Market on the basis of Distribution Channel

Hospital Pharmacies

Drug stores and Retail Pharmacies

Online Providers

Iodine Deficiency Drug Market on the basis of Dosage Form

Tablets

Others

Iodine Deficiency Drug Market on the basis of Geography

North America

Europe

Asia Pacific

Rest of the World

In the market for Distribution Channel, the market is bifurcated into Hospital Pharmacies, Drug stores and Retail Pharmacies and Online Providers. The Drug stores and Retail Pharmacies segment is likely to dominate the Iodine Deficiency Drug market growth. This is due to the surge in demand for iodine deficiency disorders and extensive usage of drugs for treatment of hypothyroidism by people in developing nations. Moreover, counseling of patients about the treatment options for common symptoms such as hypothyroidism is provided at the drug and retail pharmacies, thus providing unique benefit to the segment.

Further, on the basis of Dosage Form, the market is divided into Tablets and Others. The tablet based segment is estimated to hold a major share of the Iodine Deficiency Drug market. This is owing to the factors such as easy availability of tablets, minimum cost, easy to consume, suitable for wide range of population in developed as well as in developing nations.

In the market according to geography, the key regions are North America, Europe, Asia Pacific and Rest of the world. The North America region has the significant contribution in the Iodine Deficiency Drug market due to the rise in the healthcare infrastructure. In addition to this, the increasing awareness about the iodine deficiency will further fuel the expansion of the iodine deficiency market in region.

Moreover, the governments and healthcare organizations worldwide are creating awareness regarding the prominence of iodine in maintaining good health, particularly for pregnant women and children. This awareness is generating demand for iodine supplements and drugs worldwide. Further, iodized salt is a cost-effective and easy way to avoid iodine deficiency. The surging demand for iodized salt is propelling the demand for iodine deficiency drugs, as people who do not consume enough iodized salt may need supplements.

The report of iodine deficiency drugs market consists of profiles of the key vendors- Sanofi, Johnson & Johnson Services, Inc., Apitope Technology (Bristol) Ltd, F. Hoffmann La Roche Ltd, ILDONG PHARMACEUTICAL CO., LTD., Biotex Inc., Novartis AG, Immunovant, Inc., Lupin Pharmaceuticals, Inc., and GlaxoSmithKline plc.

The iodine deficiency is a very common disorder observed across the world which is leading to the numerous serious problems in men and women. As a result, the market for iodine deficiency drug is likely to witness a significant growth in the estimated period.

This study represents the accurate evaluation of the iodine deficiency drugs market size and its share in the parent market

Accurate estimations of future trends and changes in market dynamics are also included in this report.

This report depicts the growth analysis of the iodine deficiency drugs market industry among North America, Asia Pacific, Europe, and rest of the world.

Full analysis of the market's competitive outlook and detailed information of vendors is defined in the study.

1. Executive Summary

2. Industry Outlook

2.1. Industry Overview

2.2. Industry Trends

3. Market Snapshot

3.1. Market Definition

3.2. Market Outlook

3.2.1. Porter Five Forces

3.3. Related Markets

4. Market characteristics

4.1. Market Overview

4.2. Market Segmentation

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. DRO - Impact Analysis

5. Distribution Channel: Market Size & Analysis

5.1. Overview

5.2. Hospital Pharmacies

5.3. Drug stores and Retail Pharmacies

5.4. Online Providers

6. Dosage Form: Market Size & Analysis

6.1. Overview

6.2. Tablets

6.3. Others

7. Geography: Market Size & Analysis

7.1. Overview

7.2. North America

7.3. Europe

7.4. Asia Pacific

7.5. Rest of the World

8. Competitive Landscape

8.1. Competitor Comparison Analysis

8.2. Market Developments

8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships

8.2.2. Product Launches and execution

9. Vendor Profiles

9.1. Sanofi

9.1.1. Overview

9.1.2. Financial Overview

9.1.3. Product Offerings

9.1.4. Developments

9.1.5. Business Strategy

9.2. Johnson & Johnson Services, Inc.

9.2.1. Overview

9.2.2. Financial Overview

9.2.3. Product Offerings

9.2.4. Developments

9.2.5. Business Strategy

9.3. Apitope Technology (Bristol) Ltd

9.3.1. Overview

9.3.2. Financial Overview

9.3.3. Product Offerings

9.3.4. Developments

9.3.5. Business Strategy

9.4. F. Hoffmann La Roche Ltd

9.4.1. Overview

9.4.2. Financial Overview

9.4.3. Product Offerings

9.4.4. Developments

9.4.5. Business Strategy

9.5. ILDONG PHARMACEUTICAL CO., LTD.

9.5.1. Overview

9.5.2. Financial Overview

9.5.3. Product Offerings

9.5.4. Developments

9.5.5. Business Strategy

9.6. Biotex Inc.

9.6.1. Overview

9.6.2. Financial Overview

9.6.3. Product Offerings

9.6.4. Developments

9.6.5. Business Strategy

9.7. Novartis AG

9.7.1. Overview

9.7.2. Financial Overview

9.7.3. Product Offerings

9.7.4. Developments

9.7.5. Business Strategy

9.8. Immunovant, Inc.

9.8.1. Overview

9.8.2. Financial Overview

9.8.3. Product Offerings

9.8.4. Developments

9.8.5. Business Strategy

9.9. Lupin Pharmaceuticals, Inc.

9.9.1. Overview

9.9.2. Financial Overview

9.9.3. Product Offerings

9.9.4. Developments

9.9.5. Business Strategy

9.10. GlaxoSmithKline plc

9.10.1. Overview

9.10.2. Financial Overview

9.10.3. Product Offerings

9.10.4. Developments

9.10.5. Business Strategy

10. Analyst Opinion

11. Annexure

11.1. Report Scope

11.2. Market Definitions

11.3. Research Methodology

11.3.1. Data Collation and In-house Estimation

11.3.2. Market Triangulation

11.3.3. Forecasting

11.4. Report Assumptions

11.5. Declarations

11.6. Stakeholders

11.7. Abbreviations

TABLE 1. GLOBAL IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2026 (USD BILLION)

TABLE 2. GLOBAL IODINE DEFICIENCY DRUG MARKET VALUE FOR HOSPITAL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 3. GLOBAL IODINE DEFICIENCY DRUG MARKET VALUE FOR DRUG STORES AND RETAIL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 4. GLOBAL IODINE DEFICIENCY DRUG MARKET VALUE FOR ONLINE PROVIDERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 5. GLOBAL IODINE DEFICIENCY DRUG MARKET VALUE, BY DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 6. GLOBAL IODINE DEFICIENCY DRUG MARKET VALUE FOR TABLETS, 2021-2027 (USD BILLION)

TABLE 7. GLOBAL IODINE DEFICIENCY DRUG MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 8. NORTH AMERICA IODINE DEFICIENCY DRUG MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 9. NORTH AMERICA IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 10. NORTH AMERICA IODINE DEFICIENCY DRUG MARKET VALUE, BY DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 11. U.S IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 12. U.S IODINE DEFICIENCY DRUG MARKET VALUE, BY DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 13. CANADA IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 14. CANADA IODINE DEFICIENCY DRUG MARKET VALUE, BY DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 15. EUROPE IODINE DEFICIENCY DRUG MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 16. EUROPE IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 17. EUROPE IODINE DEFICIENCY DRUG MARKET VALUE, DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 18. GERMANY IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 19. GERMANY IODINE DEFICIENCY DRUG MARKET VALUE, BY DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 20. U.K IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 21. U.K IODINE DEFICIENCY DRUG MARKET VALUE, BY DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 22. FRANCE IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 23. FRANCE IODINE DEFICIENCY DRUG MARKET VALUE, BY DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 24. ITALY IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 25. ITALY IODINE DEFICIENCY DRUG MARKET VALUE, BY DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 26. SPAIN IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 27. SPAIN IODINE DEFICIENCY DRUG MARKET VALUE, BY DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 28. ROE IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 29. ROE IODINE DEFICIENCY DRUG MARKET VALUE, BY DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 30. ASIA PACIFC IODINE DEFICIENCY DRUG MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 31. ASIA PACIFC IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 32. ASIA PACIFC IODINE DEFICIENCY DRUG MARKET VALUE, BY DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 33. CHINA IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 34. CHINA IODINE DEFICIENCY DRUG MARKET VALUE, BY DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 35. INDIA IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 36. INDIA IODINE DEFICIENCY DRUG MARKET VALUE, BY DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 37. JAPAN IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 38. JAPAN IODINE DEFICIENCY DRUG MARKET VALUE, BY DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 39. REST OF APAC IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 40. REST OF APAC IODINE DEFICIENCY DRUG MARKET VALUE, BY DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 41. REST OF WORLD IODINE DEFICIENCY DRUG MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 42. REST OF WORLD IODINE DEFICIENCY DRUG MARKET VALUE, BY DOSAGE FORM, 2021-2027 (USD BILLION)

TABLE 43. SANOFI: FINANCIALS

TABLE 44. SANOFI: PRODUCTS & SERVICES

TABLE 45. SANOFI: RECENT DEVELOPMENTS

TABLE 46. JOHNSON & JOHNSON SERVICES, INC.: FINANCIALS

TABLE 47. JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS & SERVICES

TABLE 48. JOHNSON & JOHNSON SERVICES, INC.: RECENT DEVELOPMENTS

TABLE 49. APITOPE TECHNOLOGY (BRISTOL) LTD: FINANCIALS

TABLE 50. APITOPE TECHNOLOGY (BRISTOL) LTD: PRODUCTS & SERVICES

TABLE 51. APITOPE TECHNOLOGY (BRISTOL) LTD: RECENT DEVELOPMENTS

TABLE 52. F. HOFFMANN LA ROCHE LTD: FINANCIALS

TABLE 53. F. HOFFMANN LA ROCHE LTD: PRODUCTS & SERVICES

TABLE 54. F. HOFFMANN LA ROCHE LTD: RECENT DEVELOPMENTS

TABLE 55. ILDONG PHARMACEUTICAL CO., LTD.: FINANCIALS

TABLE 56. ILDONG PHARMACEUTICAL CO., LTD.: PRODUCTS & SERVICES

TABLE 57. ILDONG PHARMACEUTICAL CO., LTD.: RECENT DEVELOPMENTS

TABLE 58. BIOTEX INC.: FINANCIALS

TABLE 59. BIOTEX INC.: PRODUCTS & SERVICES

TABLE 60. BIOTEX INC.: RECENT DEVELOPMENTS

TABLE 61. NOVARTIS AG: FINANCIALS

TABLE 62. NOVARTIS AG: PRODUCTS & SERVICES

TABLE 63. NOVARTIS AG: RECENT DEVELOPMENTS

TABLE 64. IMMUNOVANT, INC.: FINANCIALS

TABLE 65. IMMUNOVANT, INC.: PRODUCTS & SERVICES

TABLE 66. IMMUNOVANT, INC.: RECENT DEVELOPMENTS

TABLE 67. LUPIN PHARMACEUTICALS, INC.: FINANCIALS

TABLE 68. LUPIN PHARMACEUTICALS, INC.: PRODUCTS & SERVICES

TABLE 69. LUPIN PHARMACEUTICALS, INC.: RECENT DEVELOPMENTS

TABLE 70. GLAXOSMITHKLINE PLC: FINANCIALS

TABLE 71. GLAXOSMITHKLINE PLC: PRODUCTS & SERVICES

TABLE 72. GLAXOSMITHKLINE PLC: RECENT DEVELOPMENTS

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)